EGF and IgA glomerulonephritis: In clinical settings, the urinary excretion of EGF has shown to be decreased in a wide range of kidney pathologies—e.g., diabetic nephropathy and IgA nephropathy—suggesting that it could potentially work as a biomarker of a pathway which is common to several kidney tissue insults [14].